These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31203802)

  • 21. Effects of sodium-glucose cotransporter (SGLT) inhibitors in addition to insulin therapy on glucose control and safety outcomes in adults with type 1 diabetes: A meta-analysis of randomized controlled trials.
    Lu J; Tang L; Meng H; Zhao J; Liang Y
    Diabetes Metab Res Rev; 2019 Oct; 35(7):e3169. PubMed ID: 30974510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
    Wang B; Zhong J; Lin H; Zhao Z; Yan Z; He H; Ni Y; Liu D; Zhu Z
    Diabetes Obes Metab; 2013 Aug; 15(8):737-49. PubMed ID: 23433305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials.
    Maiorino MI; Chiodini P; Bellastella G; Scappaticcio L; Longo M; Giugliano D; Esposito K
    Diabetes Res Clin Pract; 2019 Aug; 154():101-115. PubMed ID: 31238059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis.
    Zhang P; Liu Y; Ren Y; Bai J; Zhang G; Cui Y
    Afr Health Sci; 2019 Sep; 19(3):2591-2599. PubMed ID: 32127832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
    Fullerton B; Siebenhofer A; Jeitler K; Horvath K; Semlitsch T; Berghold A; Plank J; Pieber TR; Gerlach FM
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD012161. PubMed ID: 27362975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of liraglutide plus basal insulin and basal-bolus insulin therapy (BBIT) for glycemic control, body weight stability, and treatment satisfaction in patients treated using BBIT for type 2 diabetes without severe insulin deficiency: A randomized prospective pilot study.
    Yamamoto S; Hayashi T; Ohara M; Goto S; Sato J; Nagaike H; Fukase A; Sato N; Hiromura M; Tomoyasu M; Nakanishi N; Lee S; Osamura A; Yamamoto T; Fukui T; Hirano T
    Diabetes Res Clin Pract; 2018 Jun; 140():339-346. PubMed ID: 29588170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
    Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
    JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysis.
    Pittas AG; Westcott GP; Balk EM
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):886-94. PubMed ID: 26341170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs.
    Harrison LB; Mora PF; Clark GO; Lingvay I
    J Investig Med; 2013 Jan; 61(1):40-4. PubMed ID: 23222002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis.
    Amori RE; Lau J; Pittas AG
    JAMA; 2007 Jul; 298(2):194-206. PubMed ID: 17622601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of metformin on glycaemic control in patients with type 1 diabetes: A meta-analysis of randomized controlled trials.
    Meng H; Zhang A; Liang Y; Hao J; Zhang X; Lu J
    Diabetes Metab Res Rev; 2018 May; 34(4):e2983. PubMed ID: 29351716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of liraglutide on blood pressure: a meta-analysis of liraglutide randomized controlled trials.
    Zhao X; Huang K; Zheng M; Duan J
    BMC Endocr Disord; 2019 Jan; 19(1):4. PubMed ID: 30616638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis.
    Dutta D; Nagendra L; Joshi A; Krishnasamy S; Sharma M; Parajuli N
    Obes Surg; 2024 May; 34(5):1653-1664. PubMed ID: 38502519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of liraglutide for weight management in children and adolescents: a systematic review and meta-analysis of randomized controlled trials.
    Gou H; Zhai Y; Guo J
    Eur J Pediatr; 2023 Nov; 182(11):5095-5108. PubMed ID: 37672063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E-health education interventions on HbA
    Feigerlová E; Oussalah A; Zuily S; Sordet S; Braun M; Guéant JL; Guerci B
    Diabetes Metab Res Rev; 2020 Sep; 36(6):e3313. PubMed ID: 32212412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Cai X; Lin C; Yang W; Nie L; Ji L
    Diabetes Metab J; 2021 May; 45(3):312-325. PubMed ID: 33705649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of teplizumab for treatment of type 1 diabetes: A meta-analysis of randomized controlled trials.
    Heidari E; Shafiee A; Noorian S; Rafiei MA; Abbasi M; Amini MJ; Safari O; Aghamahdi F; Bakhtiyari M
    Diabetes Metab Res Rev; 2024 May; 40(4):e3806. PubMed ID: 38757421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    Song T; Jia Y; Li Z; Wang F; Ren L; Chen S
    Diabetes Ther; 2021 Jun; 12(6):1735-1749. PubMed ID: 34002333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liraglutide combined with metformin treatment for obese people with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Long Y; Zhang Y
    Ir J Med Sci; 2023 Dec; 192(6):2809-2814. PubMed ID: 37036569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liraglutide Inhibits Osteoclastogenesis and Improves Bone Loss by Downregulating Trem2 in Female Type 1 Diabetic Mice: Findings From Transcriptomics.
    Yu J; Shi YC; Ping F; Li W; Zhang HB; He SL; Zhao Y; Xu LL; Li YX
    Front Endocrinol (Lausanne); 2021; 12():763646. PubMed ID: 34975749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.